BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Adamis, Colby preclinical data

In mouse models of androgen-dependent prostate cancer and castration resistant prostate cancer (CRPC), APC-300 reduced tumor growth and prostate-specific antigen ( KLK3;...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >